Evolent Health, Inc.
Price Action
Technical Summary
CONSOLIDATINGEvolent Health, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is leading (RS Rating: 91), indicating clear outperformance against the broad market. Earnings growth of 62% provides fundamental context to the price action. However, price is extended 36% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $4.55 | +20.97% | ABOVE |
| 50 SMA | $4.04 | +36.41% | ABOVE |
| 100 SMA | $3.40 | +61.89% | ABOVE |
| 150 SMA | $3.58 | +54.00% | ABOVE |
| 200 SMA | $4.54 | +21.37% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is EVH in an uptrend right now?
EVH has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is EVH overbought or oversold?
EVH's RSI (14) is 67. The stock is in neutral territory, neither overbought nor oversold.
Is EVH outperforming the market?
EVH has a Relative Strength (RS) Rating of 91 out of 99. Yes, EVH is a market leader, outperforming 91% of all stocks over the past 12 months.
Where is EVH in its 52-week range?
EVH is trading at $5.51, which is 46% of its 52-week high ($12.07) and 34% above its 52-week low ($2.10).
How volatile is EVH?
EVH has a Beta of 0.71 and 52-week volatility of 76%. It's less volatile than the S&P 500 - generally more stable.